
    
      100-200 long-term users of NRT will be enrolled in a placebo, controlled, randomized trial
      with varenicline or placebo for 12 weeks to stop the use of NRT.

      Assessments consist of carbon monoxide in expired air, p-cotinine, body-weight, questions
      about craving, nausea and dreams. Primary result is percent not using NRT and not smoking at
      12 weeks (point prevalence last 7 days) and secondary result is not smoking and not using NRT
      at 12 months. Secondary aims, is a more detailed assessment of nausea and dreams; well-known
      side effects of varenicline and secondary results are a qualitative description of nausea and
      dreams.
    
  